
Locations
Mahwah, NJ

Washington, DC

Stroudsburg, PA
Honolulu, HI



DISCOVERY | RESEARCH | MONITOR | DATA SAFETY
Pharmacovigilance Solutions
-
Serious Adverse Event (SAE) /SUSARs management
-
Adverse Event (AE) data intake
-
Secure, accurate, and timely case entry and evaluation into validated safety database
-
Coding (MedDRA, WHO Drug)
-
Safety database
-
Annual safety reports and DSURs
-
Medical Review
-
Patient Event narrative
-
Regulatory Support and Intelligence
-
Literature Search Services
-
Report via Eudravigilance
-
Safety Medical Writing
-
Medical Information Support
Out of gallery
Data Management Statistics Analysis
Data management, data entry, database programming, drug coding, MedDRA coding, CRF design, statistical design and analysis,
[Code of Federal Regulations] [Title
[Code of Federal Regulations] [Title 21, Volume 1] [Revised as of April 1, 2009] [CITE: 21CFR1] TITLE 21-...
Out of gallery
Coronavirus disease (COVID-2019) R&D
On 31 December 2019, WHO was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China. The coronavirus disease (COVID-2019) was identified as the causative virus by Chinese authorities on 7 January. As part of WHO’s response to the outbreak, the R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. Read more...

